EMIS
Emisphere Technologies IncNASDAQFINANCIAL SERVICESSHELL COMPANIES
Key Statistics
Market Cap
$497.77M
P/E Ratio
—
EPS
$-0.10
Beta
1.41
52W High
$0.00
52W Low
$0.00
50-Day MA
$7.81
200-Day MA
$7.47
Dividend Yield
—
Profit Margin
-205.80%
Forward P/E
—
PEG Ratio
0.00
About Emisphere Technologies Inc
Emisphere Technologies, Inc. is a commercial stage pharmaceutical and drug delivery company in the United States. The company is headquartered in Roseland, New Jersey.
Fundamentals
| Revenue (TTM) | $1.04M |
| Gross Profit (TTM) | -305,000 |
| EBITDA | $-6.21M |
| Operating Margin | -596.00% |
| Return on Equity | 0.00% |
| Return on Assets | -43.30% |
| Revenue/Share (TTM) | $0.02 |
| Book Value | $-2.55 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | 457.16 |
| EV/Revenue | 540.14 |
| EV/EBITDA | 59.40 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -40.50% |
| Shares Outstanding | $60.85M |
| Float | $42.37M |
| % Insiders | 0.00% |
| % Institutions | 0.09% |
Historical Volatility
HV 10-Day
0.49%
HV 20-Day
2.90%
HV 30-Day
2.35%
HV 60-Day
2.06%
HV Rank
—
Volatility is currently contracting
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on EMIS and any ticker you trade — then tracks every position and per-strategy win rate.
More FINANCIAL SERVICES Stocks
Data last updated: 7/29/2026